- Location
1
result for "
Blood Cancer Medicine
"-
Janssen-Cilag Has Submitted MAA to EMA
Nov 1, 2013Janssen-Cilag (Janssen), a subsidiary of Johnson & Johnson pharmaceutical firm, has submitted marketing authorization application (MAA) to the European Medicines Agency (EMA) for the approval of once daily oral drug ibrutinib for the ...
Tags: Blood Cancer Medicine, Medicine
